Amphastar Pharmaceuticals (AMPH) Other Non Operating Income (2013 - 2026)

Amphastar Pharmaceuticals' Other Non Operating Income history runs 14 years deep, the most recent figure standing at $575000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 125.74% year-over-year to $575000.0; the TTM figure through Mar 2026 stood at $2.8 million (up 169.43% YoY), while the FY2025 annual figure was $23000.0, down 99.44% from the prior year.
• Other Non Operating Income was $575000.0 for Q1 2026 at Amphastar Pharmaceuticals, up from $515000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $7.6 million in Q1 2022 to a low of -$5.5 million in Q4 2023.
• Historically, Other Non Operating Income has averaged $577235.3 across 5 years, with a median of $298000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Non Operating Income sank 262.38% in 2023, then jumped 1618.21% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at $3.4 million in 2022, then tumbled by 262.38% to -$5.5 million in 2023, then surged by 153.83% to $3.0 million in 2024, then plunged by 82.55% to $515000.0 in 2025, then grew by 11.65% to $575000.0 in 2026.
• The last three Other Non Operating Income figures came in at $575000.0 (Q1 2026), $515000.0 (Q4 2025), and $231000.0 (Q3 2025), per Business Quant data.